LDN and Nausea - lactose vs acidolphillus

[Guest guest]

Thanks and Bren,

I was beginning to feel like the only one going through this. The

naseau feels like morning sickness and unfortunately detracts from

the LDN benefits.

How would I know if I am lactose intolerant? I eat cheese,

occasionally some ice cream, and last week had some wonderful sips

of a friend's milkshake. No problems from any of that. Other than

that I don't eat milk or dairy products.

I would love to hear others' experiences with lactose and

acidophillus fillers and which you'all think would be the best to

try next. Skip told me that nobody gets nauseaus from his LDN with

avicel. So I was beginning to think it was all me.

- Why do you think it would help taking the LDN with food at

bedtime? Taking LDN with food during the day is fine - as long as i

don't take it in the morning. I have a small snack about 30 minutes

before taking LDN and going to bed. Tonight I will try to take the

LDN with my snack and see what happens. There's still something

about it that seems hormonal but what do I know.

I welcome everyone's suggestions about what you think might be

causing the nausea and what I can do about it. Thanks to all, Dar

> > Hi All,

> >

> > I found an interesting research article about pregnancy and MS.

It

> says

> > that during pregancy the Th2 cells are upregulated and Th1 cells

> > downregulated.

> >

> > The same thing happens when beta endorphine level is elevated by

LDN.

> >

> > -----------------------------------------

> >

> > J Neurol Sci. 2004 Jul 15;222(1-2):21-7. Related Articles,

> Links

> >

> >

> > Th1/Th2 cytokine patterns and clinical profiles during and after

> > pregnancy in women with multiple sclerosis.

> >

> > Al-Shammri S, Rawoot P, Azizieh F, AbuQoora A, Hanna M,

Saminathan TR,

> > Raghupathy R.

> >

> > Department of Medicine, Faculty of Medicine, Kuwait University,

> P.O. Box

> > 24923, Safat 13110, Kuwait.

> >

> > Pregnancy in multiple sclerosis (MS) patients is associated with

a

> lower

> > risk of progression and lower rate of exacerbation. These

> beneficial

> > effects are reversed postpartum. Considering that the

pathogenesis

> of

> > MS appears to involve cell-mediated immune reactivity, and that

> > pregnancy is accompanied by a depressed cell-mediated immunity,

it has

> > been proposed that the lower relapse rate and risk of

> progression

> > of MS during pregnancy may be due to a pregnancy-associated down-

> > regulation of cell-mediated immunity. In addition, pregnancy

> results in a

> > shift towards a T helper (Th) 2 cytokine profile, which is

> presumably

> > protective for MS. This study was aimed at investigating the

> > relationship between clinical status of MS and cytokine levels in

> eight

> > patients with MS who were followed through pregnancy and after

> > delivery. Peripheral blood lymphocytes from these women were

> > stimulated with a mitogen at different time points during and

> after

> > gestation and the levels of Th1 cytokines (IFNgamma, TNFalpha)

and

> > Th2 cytokines (IL-4, IL-10) were estimated by ELISA. It was

> established

> > that six of the eight MS patients studied showed a distinct shift

> from a

> > Th2 cytokine bias during pregnancy towards a Th1 cytokine bias

> after

> > delivery. These results suggest a possible association between

> > decreased incidence of exacerbation of MS in pregnancy and a

> > pregnancy-induced shift towards Th2 cytokine bias.

>

>

>

>